Balance Sheet Data
Innate Pharma S.A. (IPHA)
$2.58
+0.28 (+12.17%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 167.53 | 218.87 | 151.64 | 119.84 | 101.48 | 295.94 | 443.81 | 665.59 | 998.17 | 1,496.95 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 146.64 | 13.14 | 21.69 | 18.42 | 38.35 | 69.99 | 104.97 | 157.42 | 236.08 | 354.04 |
| Account Receivables (%) | ||||||||||
| Inventories | - | 5.60 | -18.74 | -21.81 | -0 | -38.14 | -57.21 | -85.79 | -128.66 | -192.95 |
| Inventories (%) | ||||||||||
| Accounts Payable | 41.68 | 27.94 | 29.54 | 28.57 | 20.91 | 62.93 | 94.38 | 141.54 | 212.26 | 318.32 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.43 | -65.40 | -11.28 | -1.33 | -1.12 | -19.31 | -28.96 | -43.43 | -65.13 | -97.68 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.